BioXcel Therapeutics, Inc. earnings per share and revenue

BTAI earnings per share for the last quarter are -0.21 USD whereas the estimation was -0.71 USD which accounts for 70.53% surprise. Company revenue for the same period amounts to 1.10 M USD despite the estimated figure of 762.50 k USD. Estimated earnings per share for the next quarter are -0.51 USD, and revenue is expected to reach 1.33 M USD. Also watch annual changes over time to get a bigger picture of BTAI earnings per share and revenue dynamics.